Cerenome, Inc.
CNSYNasdaqCIK 1095981HealthcareFiscal year ends Dec 31
Reports and events: 425 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0211:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-411259 |
| 2026-09-1012:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-387267 |
| 2026-08-1420:35 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-352444 |
| 2026-08-1420:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-352346 |
| 2026-08-0420:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-332939 |
| 2026-06-0520:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-259703 |
| 2026-05-1520:46 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-227059 |
| 2026-05-1520:33 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-226978 |
| 2026-05-1520:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-226747 |
| 2026-04-2112:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-165205 |
| 2026-04-0912:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-148920 |
| 2026-04-0811:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-146335 |
| 2026-04-0220:30 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-140267 |
| 2026-03-3120:20 ET | DEF 14A | Proxy statementPeriod 2026-05-14 | 0001193125-26-134646 |
| 2026-03-2612:33 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-125195 |
| 2026-03-1220:35 ET | 8-K | 5.08 Item not in the standard list; 8.01 Other events | 0001193125-26-104291 |
| 2026-03-1220:29 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-104258 |
| 2026-03-1220:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-104218 |
| 2026-02-1321:09 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-051379 |
| 2026-01-2212:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-018675 |
| 2026-01-1621:05 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-015346 |
| 2026-01-0921:10 ET | S-1 | Registration statement | 0001193125-26-008922 |
| 2025-11-1712:35 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-283935 |
| 2025-10-3020:20 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-258596 |
| 2025-10-3020:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-258568 |
| 2025-10-2111:25 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-244275 |
| 2025-08-2610:30 ET | 8-K | 8.01 Other events | 0001193125-25-188075 |
| 2025-08-1420:27 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-180814 |
| 2025-08-1420:12 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-108874 |
| 2025-08-1420:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-108854 |
| 2025-08-1310:04 ET | 8-K | 8.01 Other events | 0001193125-25-179382 |
| 2025-08-1220:31 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-179012 |
| 2025-08-1220:06 ET | S-1 | Registration statement | 0001193125-25-178940 |
| 2025-07-2120:05 ET | DEF 14A | Proxy statementPeriod 2025-08-07 | 0001140361-25-026611 |
| 2025-07-1820:30 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001193125-25-161239 |
| 2025-06-2020:16 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-143665 |
| 2025-06-2001:51 ET | S-1/A | Registration statement, amended | 0001193125-25-142935 |
| 2025-06-1801:21 ET | S-1 | Registration statement | 0001193125-25-142215 |
| 2025-06-1720:25 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001193125-25-142093 |
| 2025-06-0620:22 ET | 8-K | 3.01 Delisting notice | 0001193125-25-137089 |
| 2025-05-3020:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-079749 |
| 2025-05-3020:15 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-079738 |
| 2025-05-2320:22 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-125860 |
| 2025-05-1920:20 ET | 8-K | 3.01 Delisting notice | 0000950170-25-074374 |
| 2025-05-0220:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-062742 |
| 2025-04-3020:05 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0000950170-25-061028 |
| 2025-04-1820:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-25-055883 |
| 2025-04-1020:11 ET | DEF 14A | Proxy statementPeriod 2025-05-02 | 0001140361-25-013256 |
| 2025-03-3120:06 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-047698 |
| 2025-03-2720:24 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-046110 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:02 ET. Listed shows no prices and gives no investment advice.